1. Home
  2. MGYR vs HBIO Comparison

MGYR vs HBIO Comparison

Compare MGYR & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magyar Bancorp Inc.

MGYR

Magyar Bancorp Inc.

HOLD

Current Price

$19.28

Market Cap

123.3M

Sector

Finance

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$7.92

Market Cap

26.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGYR
HBIO
Founded
1922
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
123.3M
26.5M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
MGYR
HBIO
Price
$19.28
$7.92
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.00
AVG Volume (30 Days)
1.5K
15.6K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
2.30%
N/A
EPS Growth
26.83
N/A
EPS
1.47
N/A
Revenue
N/A
$116,176,000.00
Revenue This Year
N/A
$4.77
Revenue Next Year
N/A
$8.55
P/E Ratio
$13.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.03
$0.38
52 Week High
$20.00
$8.40

Technical Indicators

Market Signals
Indicator
MGYR
HBIO
Relative Strength Index (RSI) 51.90 N/A
Support Level $16.95 N/A
Resistance Level $19.89 N/A
Average True Range (ATR) 0.37 0.00
MACD -0.04 0.00
Stochastic Oscillator 51.92 0.00

Price Performance

Historical Comparison
MGYR
HBIO

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: